Published Date: 06 Mar 2023
NEW DELHI: On Saturday, the central government authorized the Uttar Pradesh Drug Controller Authority to revoke the manufacturing license.
Read Full NewsWhile tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections.
The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...
Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.
Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.
A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.
A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.
A cascade of beneficial effects hits the brain during exercise — with new data on strength training. Helping your patients understand it can be a powerful motivator.
1.
Adopted cancer cells and the effects of their presence.
2.
Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.
3.
Breast density changes over time are associated with an increased risk of cancer.
4.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
5.
Study offers clearer picture of childhood brain tumor survival
1.
Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction
2.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
3.
The Basics of M.C.V Normal Range for Better Health Management
4.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
5.
Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation